The resident is required to successfully complete each of the following activities in order to become eligible to complete the residency program.
The resident will complete a research project that will be presented at the Eastern States Residency and Preceptors Conference. This project can be of original research, a problem-solving exercise or development, enhancement or evaluation of some aspect of pharmacy services. A publication quality manuscript of the residency project must be submitted to the Residency Director prior to completion of the program.
PGY-1 and PGY-2 pharmacy residents are required to prepare and present two formal case presentations during their residency. The goal of a case presentation is to discuss the drug therapy of a rare disease state or to discuss a controversial drug therapy issue of a common disease state related to a particular patient case.
PGY-1 and PGY-2 pharmacy residents prepare and present one formal ACPE (American Council on Pharmacy Education) accredited pharmacy seminar during the residency year. The goal of the seminar is to expand the resident's communication skills and presentation techniques. The seminar topic will involve a therapeutic or practice management controversy, clinical or practice management research or review of a specific therapeutic area.
PGY-1 and PGY-2 pharmacy residents will present two (PGY-2) or three (PGY-1) formal journal clubs during the residency year. This experience is designed to help residents evaluate and appraise medical literature through the evaluation of statistical methods used, the statistical significance and clinical significance of study results as well as the impact on current and future practice.
BLS certification is required of all PGY-1 and PGY-2 critical care pharmacy residents. ACLS is optional for PGY-2 Infectious Diseases and Solid Organ Transplantation pharmacy residents.
The purpose of this learning experience is to expand the PGY-2 critical care pharmacy resident's learning experience in adult cardiopulmonary arrests outside the intensive care unit (ICU). This is an optional experience for PGY-1 residents.
The Resident Discussion Series is a forum where residents learn about identified topics of interest in pharmacy practice. These discussions are designed to aid in the professional development of the residents and are scheduled to address timely concerns that the residents will encounter over the residency year.
PGY-1 pharmacy residents will attend monthly Formulary and Therapeutics Committee meetings and participate in activities as deemed appropriate. PGY-2 pharmacy residents will join a subcommittee in their specialty area.
PGY-1 pharmacy residents are expected to be on-site at the Weill Cornell campus each day, every other weekend. Duties are as follows:
PGY-2 pharmacy residents are expected to be on-site at their assigned institution every other Saturday. Duties will be specific to the program.
A limited (Intern) permit or NYS pharmacist license is required prior to the start of the residency. PGY-2 residents who are licensed as a pharmacist in another state do not need a limited (Intern) permit unless their NYS pharmacist license will be delayed.
All residents are required to be licensed as a pharmacist in the state of New York by October 1st. This may be accomplished by primary examination, score transfer or reciprocation.
Residents seeking NYS licensure through primary examination may complete the compounding exam offered by NewYork-Presbyterian Hospital in place of Part III of the New York State board exam (compounding exam). Residents who take Part III of the NYS board exam and do not pass, must retake the state exam again in January and are not eligible to take the compounding exam offered by NewYork-Presbyterian Hospital.